Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure
Several mechanisms participate in the down-regulation of growth hormone receptor (GHR) signalling under ligand exposure. In CHO cells expressing GHR, we show that ligand stimulation induces degradation of the total cell GHR content. Experiments with 125I-hGH indicate that ligand-bound internalized r...
Gespeichert in:
Veröffentlicht in: | Cellular signalling 2003, Vol.15 (1), p.47-55 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 55 |
---|---|
container_issue | 1 |
container_start_page | 47 |
container_title | Cellular signalling |
container_volume | 15 |
creator | Moulin, Stéphanie Bouzinba-Segard, Haniaa Kelly, Paul A Finidori, Joëlle |
description | Several mechanisms participate in the down-regulation of growth hormone receptor (GHR) signalling under ligand exposure. In CHO cells expressing GHR, we show that ligand stimulation induces degradation of the total cell GHR content. Experiments with
125I-hGH indicate that ligand-bound internalized receptors are not immediately replaced. Using cell surface biotinylation, we demonstrate for the first time that, concomitantly with the degradation of cell surface receptors, GHRs from the intracellular compartments are also degraded. We thus suggest that under prolonged ligand exposure, some GHRs are targeted to the cell surface, while others are routed to degradation compartments. Inhibitors of Jak2 and of the proteasome partially inhibited degradation of cell surface receptors, while these compounds completely inhibit the degradation of intracellular GHRs, resulting in their accumulation. We therefore propose that Jak2 and proteasome activities control the amount of intracellular GHRs, and thus the availability of receptors at the cell surface, during ligand exposure. |
doi_str_mv | 10.1016/S0898-6568(02)00054-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72882583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0898656802000542</els_id><sourcerecordid>72882583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-eddc190c439b96597694e08c5d4ce8aa5b3de00aadf7acbc6310a1cb9fefd27b3</originalsourceid><addsrcrecordid>eNqFkF1vFCEUhomxsWvtT9BwZfRi9ADzAVfGNP3QNPFCe00YOLOLzgwrMNv238t2N3rpFYQ8L-85DyGvGXxgwNqP30EqWbVNK98Bfw8ATV3xZ2TFZCcqoZh4TlZ_kVPyMqWfAKyBlr8gp4zX5c7Uitx_Nb84NbOj2xgymhQmpMZmv_PZY6I2zDmGkeZNed4ZP5rejz4_0jBQi-NI0xIHY5GuY7jPG7oJcQoz0ogWtznERN0S_bymo1_vW_BhG0oEX5GTwYwJz4_nGbm7uvxxcVPdfrv-cvH5trKiZblC5yxTYGuhetU2qmtVjSBt42qL0pimFw4BjHFDZ2xvW8HAMNurAQfHu16ckbeHf8t6vxdMWU8-7Qc3M4Yl6Y5LyRspCtgcQBtDShEHvY1-MvFRM9B74_rJuN7r1MD1k3HNS-7NsWDpJ3T_UkfFBfh0ALCsufMYdbIeZ4vOF0lZu-D_U_EHBxqUXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72882583</pqid></control><display><type>article</type><title>Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Moulin, Stéphanie ; Bouzinba-Segard, Haniaa ; Kelly, Paul A ; Finidori, Joëlle</creator><creatorcontrib>Moulin, Stéphanie ; Bouzinba-Segard, Haniaa ; Kelly, Paul A ; Finidori, Joëlle</creatorcontrib><description>Several mechanisms participate in the down-regulation of growth hormone receptor (GHR) signalling under ligand exposure. In CHO cells expressing GHR, we show that ligand stimulation induces degradation of the total cell GHR content. Experiments with
125I-hGH indicate that ligand-bound internalized receptors are not immediately replaced. Using cell surface biotinylation, we demonstrate for the first time that, concomitantly with the degradation of cell surface receptors, GHRs from the intracellular compartments are also degraded. We thus suggest that under prolonged ligand exposure, some GHRs are targeted to the cell surface, while others are routed to degradation compartments. Inhibitors of Jak2 and of the proteasome partially inhibited degradation of cell surface receptors, while these compounds completely inhibit the degradation of intracellular GHRs, resulting in their accumulation. We therefore propose that Jak2 and proteasome activities control the amount of intracellular GHRs, and thus the availability of receptors at the cell surface, during ligand exposure.</description><identifier>ISSN: 0898-6568</identifier><identifier>EISSN: 1873-3913</identifier><identifier>DOI: 10.1016/S0898-6568(02)00054-2</identifier><identifier>PMID: 12401519</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Animals ; Cell Compartmentation ; Cell Membrane - metabolism ; CHO Cells ; Cricetinae ; Cysteine Endopeptidases - metabolism ; Cysteine Endopeptidases - physiology ; Cysteine Proteinase Inhibitors - pharmacology ; Down-Regulation ; Growth hormone ; Growth Hormone - metabolism ; Internalization ; Jak2 ; Janus Kinase 2 ; Kinetics ; Ligands ; Models, Biological ; Multienzyme Complexes - antagonists & inhibitors ; Multienzyme Complexes - metabolism ; Multienzyme Complexes - physiology ; Proteasome ; Proteasome Endopeptidase Complex ; Protein Transport ; Protein-Tyrosine Kinases - metabolism ; Protein-Tyrosine Kinases - physiology ; Proto-Oncogene Proteins ; Receptor degradation ; Receptors, Somatotropin - metabolism</subject><ispartof>Cellular signalling, 2003, Vol.15 (1), p.47-55</ispartof><rights>2002 Elsevier Science Inc.</rights><rights>Copyright 2002 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-eddc190c439b96597694e08c5d4ce8aa5b3de00aadf7acbc6310a1cb9fefd27b3</citedby><cites>FETCH-LOGICAL-c361t-eddc190c439b96597694e08c5d4ce8aa5b3de00aadf7acbc6310a1cb9fefd27b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0898656802000542$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12401519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moulin, Stéphanie</creatorcontrib><creatorcontrib>Bouzinba-Segard, Haniaa</creatorcontrib><creatorcontrib>Kelly, Paul A</creatorcontrib><creatorcontrib>Finidori, Joëlle</creatorcontrib><title>Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure</title><title>Cellular signalling</title><addtitle>Cell Signal</addtitle><description>Several mechanisms participate in the down-regulation of growth hormone receptor (GHR) signalling under ligand exposure. In CHO cells expressing GHR, we show that ligand stimulation induces degradation of the total cell GHR content. Experiments with
125I-hGH indicate that ligand-bound internalized receptors are not immediately replaced. Using cell surface biotinylation, we demonstrate for the first time that, concomitantly with the degradation of cell surface receptors, GHRs from the intracellular compartments are also degraded. We thus suggest that under prolonged ligand exposure, some GHRs are targeted to the cell surface, while others are routed to degradation compartments. Inhibitors of Jak2 and of the proteasome partially inhibited degradation of cell surface receptors, while these compounds completely inhibit the degradation of intracellular GHRs, resulting in their accumulation. We therefore propose that Jak2 and proteasome activities control the amount of intracellular GHRs, and thus the availability of receptors at the cell surface, during ligand exposure.</description><subject>Animals</subject><subject>Cell Compartmentation</subject><subject>Cell Membrane - metabolism</subject><subject>CHO Cells</subject><subject>Cricetinae</subject><subject>Cysteine Endopeptidases - metabolism</subject><subject>Cysteine Endopeptidases - physiology</subject><subject>Cysteine Proteinase Inhibitors - pharmacology</subject><subject>Down-Regulation</subject><subject>Growth hormone</subject><subject>Growth Hormone - metabolism</subject><subject>Internalization</subject><subject>Jak2</subject><subject>Janus Kinase 2</subject><subject>Kinetics</subject><subject>Ligands</subject><subject>Models, Biological</subject><subject>Multienzyme Complexes - antagonists & inhibitors</subject><subject>Multienzyme Complexes - metabolism</subject><subject>Multienzyme Complexes - physiology</subject><subject>Proteasome</subject><subject>Proteasome Endopeptidase Complex</subject><subject>Protein Transport</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Protein-Tyrosine Kinases - physiology</subject><subject>Proto-Oncogene Proteins</subject><subject>Receptor degradation</subject><subject>Receptors, Somatotropin - metabolism</subject><issn>0898-6568</issn><issn>1873-3913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1vFCEUhomxsWvtT9BwZfRi9ADzAVfGNP3QNPFCe00YOLOLzgwrMNv238t2N3rpFYQ8L-85DyGvGXxgwNqP30EqWbVNK98Bfw8ATV3xZ2TFZCcqoZh4TlZ_kVPyMqWfAKyBlr8gp4zX5c7Uitx_Nb84NbOj2xgymhQmpMZmv_PZY6I2zDmGkeZNed4ZP5rejz4_0jBQi-NI0xIHY5GuY7jPG7oJcQoz0ogWtznERN0S_bymo1_vW_BhG0oEX5GTwYwJz4_nGbm7uvxxcVPdfrv-cvH5trKiZblC5yxTYGuhetU2qmtVjSBt42qL0pimFw4BjHFDZ2xvW8HAMNurAQfHu16ckbeHf8t6vxdMWU8-7Qc3M4Yl6Y5LyRspCtgcQBtDShEHvY1-MvFRM9B74_rJuN7r1MD1k3HNS-7NsWDpJ3T_UkfFBfh0ALCsufMYdbIeZ4vOF0lZu-D_U_EHBxqUXg</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>Moulin, Stéphanie</creator><creator>Bouzinba-Segard, Haniaa</creator><creator>Kelly, Paul A</creator><creator>Finidori, Joëlle</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2003</creationdate><title>Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure</title><author>Moulin, Stéphanie ; Bouzinba-Segard, Haniaa ; Kelly, Paul A ; Finidori, Joëlle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-eddc190c439b96597694e08c5d4ce8aa5b3de00aadf7acbc6310a1cb9fefd27b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Cell Compartmentation</topic><topic>Cell Membrane - metabolism</topic><topic>CHO Cells</topic><topic>Cricetinae</topic><topic>Cysteine Endopeptidases - metabolism</topic><topic>Cysteine Endopeptidases - physiology</topic><topic>Cysteine Proteinase Inhibitors - pharmacology</topic><topic>Down-Regulation</topic><topic>Growth hormone</topic><topic>Growth Hormone - metabolism</topic><topic>Internalization</topic><topic>Jak2</topic><topic>Janus Kinase 2</topic><topic>Kinetics</topic><topic>Ligands</topic><topic>Models, Biological</topic><topic>Multienzyme Complexes - antagonists & inhibitors</topic><topic>Multienzyme Complexes - metabolism</topic><topic>Multienzyme Complexes - physiology</topic><topic>Proteasome</topic><topic>Proteasome Endopeptidase Complex</topic><topic>Protein Transport</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Protein-Tyrosine Kinases - physiology</topic><topic>Proto-Oncogene Proteins</topic><topic>Receptor degradation</topic><topic>Receptors, Somatotropin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moulin, Stéphanie</creatorcontrib><creatorcontrib>Bouzinba-Segard, Haniaa</creatorcontrib><creatorcontrib>Kelly, Paul A</creatorcontrib><creatorcontrib>Finidori, Joëlle</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cellular signalling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moulin, Stéphanie</au><au>Bouzinba-Segard, Haniaa</au><au>Kelly, Paul A</au><au>Finidori, Joëlle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure</atitle><jtitle>Cellular signalling</jtitle><addtitle>Cell Signal</addtitle><date>2003</date><risdate>2003</risdate><volume>15</volume><issue>1</issue><spage>47</spage><epage>55</epage><pages>47-55</pages><issn>0898-6568</issn><eissn>1873-3913</eissn><abstract>Several mechanisms participate in the down-regulation of growth hormone receptor (GHR) signalling under ligand exposure. In CHO cells expressing GHR, we show that ligand stimulation induces degradation of the total cell GHR content. Experiments with
125I-hGH indicate that ligand-bound internalized receptors are not immediately replaced. Using cell surface biotinylation, we demonstrate for the first time that, concomitantly with the degradation of cell surface receptors, GHRs from the intracellular compartments are also degraded. We thus suggest that under prolonged ligand exposure, some GHRs are targeted to the cell surface, while others are routed to degradation compartments. Inhibitors of Jak2 and of the proteasome partially inhibited degradation of cell surface receptors, while these compounds completely inhibit the degradation of intracellular GHRs, resulting in their accumulation. We therefore propose that Jak2 and proteasome activities control the amount of intracellular GHRs, and thus the availability of receptors at the cell surface, during ligand exposure.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>12401519</pmid><doi>10.1016/S0898-6568(02)00054-2</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0898-6568 |
ispartof | Cellular signalling, 2003, Vol.15 (1), p.47-55 |
issn | 0898-6568 1873-3913 |
language | eng |
recordid | cdi_proquest_miscellaneous_72882583 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Cell Compartmentation Cell Membrane - metabolism CHO Cells Cricetinae Cysteine Endopeptidases - metabolism Cysteine Endopeptidases - physiology Cysteine Proteinase Inhibitors - pharmacology Down-Regulation Growth hormone Growth Hormone - metabolism Internalization Jak2 Janus Kinase 2 Kinetics Ligands Models, Biological Multienzyme Complexes - antagonists & inhibitors Multienzyme Complexes - metabolism Multienzyme Complexes - physiology Proteasome Proteasome Endopeptidase Complex Protein Transport Protein-Tyrosine Kinases - metabolism Protein-Tyrosine Kinases - physiology Proto-Oncogene Proteins Receptor degradation Receptors, Somatotropin - metabolism |
title | Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A55%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Jak2%20and%20proteasome%20activities%20control%20the%20availability%20of%20cell%20surface%20growth%20hormone%20receptors%20during%20ligand%20exposure&rft.jtitle=Cellular%20signalling&rft.au=Moulin,%20St%C3%A9phanie&rft.date=2003&rft.volume=15&rft.issue=1&rft.spage=47&rft.epage=55&rft.pages=47-55&rft.issn=0898-6568&rft.eissn=1873-3913&rft_id=info:doi/10.1016/S0898-6568(02)00054-2&rft_dat=%3Cproquest_cross%3E72882583%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72882583&rft_id=info:pmid/12401519&rft_els_id=S0898656802000542&rfr_iscdi=true |